Your browser doesn't support javascript.
loading
Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burden.
Schwotzer, Rahel; Manz, Markus Gabriel; Pederiva, Stefanie; Waibel, Christine; Caspar, Clemens; Lerch, Erika; Flammer, Andreas J; Brouwers, Sofie; Seeger, Harald; Heimgartner, Raphael; Fehr, Thomas; Rossi, Davide; Bianchi, Elena; Stüssi, Georg; Ghilardi, Guido; Gerber, Bernhard.
Afiliación
  • Schwotzer R; Department of Medical Oncology and Hematology, University and University Hospital Zürich, Zürich, Switzerland.
  • Manz MG; Department of Medical Oncology and Hematology, University and University Hospital Zürich, Zürich, Switzerland.
  • Pederiva S; Division of Hematology and Oncology, Kantonsspital Baden, Baden, Switzerland.
  • Waibel C; Division of Hematology and Oncology, Kantonsspital Baden, Baden, Switzerland.
  • Caspar C; Division of Hematology and Oncology, Kantonsspital Baden, Baden, Switzerland.
  • Lerch E; Division of Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Flammer AJ; University Heart Center, University and University Hospital Zürich, Zürich, Switzerland.
  • Brouwers S; University Heart Center, University and University Hospital Zürich, Zürich, Switzerland.
  • Seeger H; Division of Nephrology, University and University Hospital Zürich, Zürich, Switzerland.
  • Heimgartner R; Department of Internal Medicine, Cantonal Hospital Graubünden, Chur, Switzerland.
  • Fehr T; Department of Internal Medicine, Cantonal Hospital Graubünden, Chur, Switzerland.
  • Rossi D; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Bianchi E; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Stüssi G; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Ghilardi G; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Gerber B; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Hematol Oncol ; 37(5): 595-600, 2019 Dec.
Article en En | MEDLINE | ID: mdl-31486522
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Plasmáticas / Recuento de Linfocitos / Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / Antineoplásicos Inmunológicos / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Año: 2019 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Plasmáticas / Recuento de Linfocitos / Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / Antineoplásicos Inmunológicos / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Año: 2019 Tipo del documento: Article País de afiliación: Suiza